Post by : Badri Ariffin

In a bid to fortify supply chains and cultivate a regulatory framework that aligns with global best practices, Abu Dhabi Customs, collaborating with the Emirates Drug Establishment, has unveiled the Golden List of Pharmaceutical Companies.

This initiative seeks to strike a balance between pharmaceutical safety and efficient trade operations, facilitating smoother movements for shipments at Abu Dhabi’s border ports. Moreover, it ties into the UAE’s We the UAE 2031 vision, promoting advancements in health innovation and sustainability.

The inaugural phase showcases 31 accredited pharmaceutical firms. These entities will experience benefits such as streamlined customs procedures, improved compliance measures, and expedited shipment processing. The facilitation involves prompt shipment accreditation and quicker customs clearance within the seamless customs framework.

This launch further cements Abu Dhabi’s significance as a pharmaceutical manufacturing hub within the UAE, contributing approximately 27% to the nation's overall pharmaceutical output. Thus, this initiative is pivotal for national health security as well as enhancing global competitiveness.

H.E. Rashed Lahej Al Mansoori, Director General of Abu Dhabi Customs, noted that the Golden List underscores the importance of strategic alliances between government entities and the private sector. He remarked on its ability to heighten regulatory efficiency, enabling compliant companies to leverage flexible customs pathways without sacrificing safety.

H.E. Dr. Fatima Al Kaabi, Director General of the Emirates Drug Establishment, highlighted that this initiative signifies robust institutional collaboration and a commitment to pharmaceutical safety. She emphasized its role in promoting investments in high-value pharmaceutical sectors, streamlining procedures for compliant firms, and bolstering the UAE’s stance in global pharmaceutical production.

To join the Golden List, companies must fulfill various prerequisites, including:

• A proven history of customs adherence with no significant infractions

• Effective risk management and internal control frameworks

• Preparedness to comply with technical demands from relevant authorities

• Complete compliance with Emirates Drug Establishment standards

This initiative is poised to bolster transparency, efficiency, and competitiveness in Abu Dhabi’s pharmaceutical industry while advancing the UAE’s overarching economic and health security aspirations.

#Global News